Barrio-Real L, Lopez-Haber C, Casado-Medrano V, Goglia A, Toettcher J, Caloca M, Kazanietz M. P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer. Oncotarget. 2018;9(47):28612–28624. PMCID: PMC6033363